Key facts
- This page summarizes Jerald Korn's Form 4 filing for Kaleido Biosciences, Inc..
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 02 Mar 2022, 15:05.
Jerald Korn - 28 Feb 2022 Form 4 Insider Report for Kaleido Biosciences, Inc.
- Reporting relationship
- COO & General Counsel
- Issuer ticker
- N/A
- Reported as of
- 28 Feb 2022
- Net transaction value
- -$3,049
- SEC form
- 4
- Accepted by SEC
- 02 Mar 2022, 15:05:37 UTC
- Prior SEC filing
- 18 Jan 2022
- Next SEC filing
- 21 Mar 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/Jerald Korn
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jerald Korn filed Form 4 for Kaleido Biosciences, Inc. on 02 Mar 2022.
Change
- Previous filing in this sequence was filed on 18 Jan 2022.
- Current net transaction value: -$3,049.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KLDO
transaction
Restricted Stock Units
Tax liability
- Transaction value
- $3,049
- Shares
- -2,046
- Change %
- -31%
- Price
- $1.49*
- Shares after
- 4,517
- Date
- 28 Feb 2022
- Ownership
- Direct
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents shares withheld to cover income taxes resulting from vesting of restricted stock units on February 28, 2022